Piecing Together The Interoperability Puzzle: Q&A With Julian Goldman
This article was originally published in The Gray Sheet
Executive Summary
In a recent interview with “The Gray Sheet,” the founding director of the Medical Device Interoperability Program describes an ongoing effort to establish a clearer FDA pathway for devices designed to seamlessly communicate with other products, even those made by different manufacturers.
You may also be interested in...
J&J’s Sedasys Sedation System Now “Approvable,” Though Some Questions Remain
Outstanding FDA questions pertain to follow-up data, user training and “post-market observance and those sorts of things,” CFO Dominic Caruso told investors during the firm’s first-quarter earnings call April 17.
FDA Medical Device Data Systems Rule Still Raising Questions
While a mid-May deadline has come and gone for makers of "medical device data systems" to register their products with FDA, many are still wondering whether their offerings fall within the agency’s definition of the newly classified device category.
"Plug And Play" Medical Systems Raise Complicated Regulatory Questions
FDA, device makers and others are struggling to identify the best way to regulate "interoperable" medical systems - such as an iPhone that receives blood glucose data - with some suggesting that a separate classification scheme might be needed